Business Wire

Percona Announces General Availability of Percona Platform

Share

Percona, a leader in open source database software and services, today announced the general availability of Percona Platform, which brings the company’s expertise with databases including MySQL®, PostgreSQL® and MongoDB® together alongside services, management and automated insights into a single product. Using the company’s experience in managing and improving some of the largest database installations in the world, Percona Platform helps users monitor, manage, secure and optimize their database instances across any infrastructure.

“Percona Platform brings the experience and expertise that we have built up over the years and puts it in the hands of developers and database administrators to use. It includes AI-powered recommendations that help users improve performance, management and security, as well as making it easier to scale up and manage their instances over time. With Percona Platform, we thought about how to improve the experience for developers and DBAs around running their data workloads, and how to help people achieve their goals faster around managing databases as part of their overall approach,” said Donnie Berkholz, Senior Vice President Product at Percona.

“Developers want to improve their efficiency and experience across their tasks, and databases are no exception. Improving this will be an area of investment for companies - whether this involves time for their staff to implement projects, or investing in cloud services to provide the tools they need. Percona’s approach to this challenge aims to provide self-managed control and internal ownership as well as the flexibility and ease of use that many companies tout with their DBaaS offerings. By offering a fully open source compatible service, Percona is looking to plug a gap in the market that many database companies are not able to cover,” commented Bradley Shimmin, Chief Analyst, AI platforms, analytics and data management at Omdia.

“There has been an explosion of data tools available to enterprises, which in turn has led to rampant fragmentation and highly complex, disjointed workflows. Organizations that prize velocity are looking for ways to integrate various data tools into their broader development workflows and monitor them. This is the opportunity that Percona Platform is built for. The combination of software and services in this space is intended to help customers better manage their database deployments,” commented Rachel Stephens, Senior Analyst, RedMonk.

“Percona has woven over a decade of open-source database expertise into a consistent, modern database experience for all organizations, from any cloud to on-premises. With Percona Platform we have built out our open source database software offerings, bolstered by automated insights, self-service operations, and the best database observability and management tools in the market. This launch will help us scale our business and create a sustainable model in the age of cloud, while respecting the freedom and accessibility that is open source. We have seen other companies turn away from open source and adopt closed source licenses in order to maximize their profitability, which we think is not in the best interests of customers. Our approach makes our expertise available to all our customers and users, putting their needs first,” added Ann Schlemmer, President at Percona.

Percona Platform is the culmination of the company’s work to expand and deliver its wide-ranging knowledge of databases into products that users can deploy quickly and use to improve their performance. As part of the launch, Percona has used its service expertise to create automated recommendation products called Advisors for customers that can help them immediately improve their results. It supports all deployment configurations, from public, private and hybrid cloud instances through to internal data center deployments. It supports both self-managed and Percona-managed instances, letting customers approach their database management in the way that suits them.

Percona Platform includes the following elements:

  • Percona Portal - access to all Percona services and product expertise through one unified online portal, covering multiple databases with enterprise-level features including backup, security, management, optimization and more
  • Percona Monitoring and Management (PMM) - a database management product that is fully open source itself, allowing developers and DBAs to streamline their management tasks across multiple platforms from one place
  • New range of Advisors - automated insights that ensure user databases are performing at their best, including security management, configuration and performance improvements
  • Private DBaaS Technical Preview - this will support companies deploying their own DBaaS internally using open source database distributions, Percona management tool PMM and Kubernetes operators for MySQL and PostgreSQL. It will also support the same approach for MongoDB. This enables users to easily provision and manage database instances on a self-service basis across development and testing instances, improving the experience for developers
  • Percona Account - simplified user account management for all Percona products and services under one account

Links

About Percona

Databases run better with Percona. Percona is the only company that delivers enterprise-class products, support and services for a range of open source databases including MySQL®, MariaDB®, MongoDB®, and PostgreSQL across traditional deployments, cloud-based platforms and hybrid IT environments. The company is committed to supporting open source as an approach to software licensing, development and deployment - its database management tools are used by millions of application developers, database administrators and IT professionals worldwide.

Percona equips businesses with the freedom to choose, the freedom to create, and the freedom to make a difference — helping them scale with speed as they grow. The company supports global brands such as PayPal, Vimeo, RockStar Games, Duolingo, Fiserv, Slack, Cisco Systems, and Rent the Runway, as well as smaller enterprises looking to maximize application performance while streamlining database efficiencies. For more information, visit www.percona.com.

Percona® is a registered trademark of Percona LLC. All other registered and unregistered trademarks in this document are the sole property of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press Contacts
Mark Kember
onebite for Percona
percona@onebite.co.uk

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection

Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release

Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played

Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release

At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will

Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release

Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release

MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye